Hereditary spherocytosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 35: | Line 35: | ||
==Treatment== | ==Treatment== | ||
[[Hereditary spherocytosis medical therapy|Medical Therapy]] | [[Hereditary spherocytosis surgery |Surgery | [[Hereditary spherocytosis medical therapy|Medical Therapy]] | [[Hereditary spherocytosis surgery |Surgery]] | [[Hereditary spherocytosis secondary prevention|Secondary Prevention]] | [[Hereditary spherocytosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hereditary spherocytosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 17:25, 21 September 2012
Template:DiseaseDisorder infobox
|
Hereditary spherocytosis Microchapters |
|
Differentiating Hereditary spherocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hereditary spherocytosis On the Web |
|
American Roentgen Ray Society Images of Hereditary spherocytosis |
|
Risk calculators and risk factors for Hereditary spherocytosis |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Hereditary spherocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies